chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vomiting
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of VOMITING (vomited 3 times in 7 days) and FATIGUE (still feels tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomited 3 times in 7 days) and FATIGUE (still feels tired). At the time of the report, VOMITING (vomited 3 times in 7 days) outcome was unknown and FATIGUE (still feels tired) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs and treatment medications were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: after vaccination, the staff realized that this patient was only 19 days post first vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (after vaccination, the staff realized that this patient was only 19 days post first vaccine) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (after vaccination, the staff realized that this patient was only 19 days post first vaccine). On 06-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (after vaccination, the staff realized that this patient was only 19 days post first vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Inappropriate schedule of product administration
Clinical narrative: shingles; Second dose given on day 25 after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 25 after first dose) and HERPES ZOSTER (shingles) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 25 after first dose). On 30-Mar-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, at a dose of UNK dosage form. On 28-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose given on day 25 after first dose) had resolved. At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.            No concomitant medications were provided.  .
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gingival swelling, Hypoaesthesia oral, Oral pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (lower oral pain along left gum line), GINGIVAL SWELLING (swelling inside mouth along left gum line), HYPOAESTHESIA ORAL (numbness) and FEELING ABNORMAL (more bothersome than painful) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1003B21A) for COVID-19 vaccination.     The patient's past medical history included Gum disorder (gum resection and grafting.). Concomitant products included MULTI VIT and ECHINACEA PURPUREA ROOT, OLEA EUROPAEA LEAF, SAMBUCUS NIGRA FRUIT (ELDERBERRY ECHINACEA & OLIVE LEAF) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced ORAL PAIN (lower oral pain along left gum line) and GINGIVAL SWELLING (swelling inside mouth along left gum line). On 13-Apr-2021, the patient experienced HYPOAESTHESIA ORAL (numbness) and FEELING ABNORMAL (more bothersome than painful). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of UNK dosage form. At the time of the report, ORAL PAIN (lower oral pain along left gum line) and HYPOAESTHESIA ORAL (numbness) was resolving and GINGIVAL SWELLING (swelling inside mouth along left gum line) and FEELING ABNORMAL (more bothersome than painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-075037 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Improper storage and handling; Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Improper storage and handling) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Dec-2020, the patient experienced PRODUCT STORAGE ERROR (Improper storage and handling) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Feb-2021, PRODUCT STORAGE ERROR (Improper storage and handling) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   PA is calling in reference to a previous case (MOD21-023542). Their vaccination site was not following proper storage and handling guidelines from 23DEC2020 to 8FEB2021. He stated that they did a wild net audit and it is possible that about 102 patients were affected, up from 50 that was mentioned in the initial case. They gave vaccination from vials after 6 hours, in some instances it was longer than 24 hours from the time of initially needle punctured.  No treatment medication were reported. Several lot numbers were involved. PA did not have patients demographics or lot numbers at his finger tips.   This case was linked to US-MODERNATX, INC.-MOD-2021-011911 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26-May-2021. It contains NNI; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-011911:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Nausea, Rash, Vaccination site pain
Clinical narrative: Has not felt good since; rash on wrist/ rash on forearm/ rash on back; headache; nausea; vomiting; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea) and VOMITING (vomiting) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (codeine), High cholesterol and Contrast media allergy.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medications were reported.  No treatment was provided.   This case was linked to MOD-2021-074965 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Has not felt good since; rash on wrist/ rash on forearm/ rash on back; headache; nausea; vomiting; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea) and VOMITING (vomiting) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (codeine), High cholesterol and Contrast media allergy.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, MALAISE (Has not felt good since), RASH (rash on wrist/ rash on forearm/ rash on back), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medications were reported.  No treatment was provided.   This case was linked to MOD-2021-074965 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Mass
Clinical narrative: soft lump; a little sore; swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of MASS (soft lump), LYMPH NODE PAIN (a little sore) and LYMPHADENOPATHY (swollen lymph node) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced MASS (soft lump), LYMPH NODE PAIN (a little sore) and LYMPHADENOPATHY (swollen lymph node). At the time of the report, MASS (soft lump), LYMPH NODE PAIN (a little sore) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No corrective treatment was provided.   This case was linked to -MODERNATX, INC.-MOD-2021-074960, -MODERNATX, INC.-MOD-2021-074909, US-MODERNATX, INC.-MOD-2021-074886 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Illness, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: did not get second dose; started to get sick; covid-19; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not get second dose), ILLNESS (started to get sick) and COVID-19 (covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ILLNESS (started to get sick) and COVID-19 (covid-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not get second dose), ILLNESS (started to get sick) and COVID-19 (covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. Patient reported On 29-Jan-2021 she had an infusion to treat COVID-19.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: sensation of a tingling feeling from behind my knees and down each leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (sensation of a tingling feeling from behind my knees and down each leg) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Demarol).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced PARAESTHESIA (sensation of a tingling feeling from behind my knees and down each leg). At the time of the report, PARAESTHESIA (sensation of a tingling feeling from behind my knees and down each leg) outcome was unknown.            Action taken wit mRNA-1273 in response to the events was not applicable.  Concomitant medications and Treatment information were not provided.   This case was linked to MOD-2021-074946 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Patient demographics updated, allergy to demarol added, dose details added.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Confusional state, Dizziness, Memory impairment
Clinical narrative: Does not remember things well and has confusion; Pain in the body and hands; Pain in the body and hands; Does not remember things well and has confusion; Fever; Nausea; Pain in the shoulder; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Does not remember things well and has confusion), DIZZINESS (Dizziness), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands) and PAIN (Pain in the body and hands) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0162B1A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve replacement.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), NAUSEA (Nausea) and ARTHRALGIA (Pain in the shoulder). On 08-Apr-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced MEMORY IMPAIRMENT (Does not remember things well and has confusion), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands) and PAIN (Pain in the body and hands). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 2 UNK. On 12-Apr-2021, ARTHRALGIA (Pain in the shoulder) had resolved. At the time of the report, MEMORY IMPAIRMENT (Does not remember things well and has confusion), DIZZINESS (Dizziness), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands), PAIN (Pain in the body and hands), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 100.5 (High) 100.5 ° F.         No concomitant medications were provided by the reporter.  Patient also applied towel with cold water to treat the fever.   This case was linked to MOD-2021-075688, MOD-2021-075591 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Does not remember things well and has confusion; Pain in the body and hands; Pain in the body and hands; Does not remember things well and has confusion; Fever; Nausea; Pain in the shoulder; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Does not remember things well and has confusion), DIZZINESS (Dizziness), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands) and PAIN (Pain in the body and hands) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0162B1A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve replacement.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), NAUSEA (Nausea) and ARTHRALGIA (Pain in the shoulder). On 08-Apr-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced MEMORY IMPAIRMENT (Does not remember things well and has confusion), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands) and PAIN (Pain in the body and hands). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 2 UNK. On 12-Apr-2021, ARTHRALGIA (Pain in the shoulder) had resolved. At the time of the report, MEMORY IMPAIRMENT (Does not remember things well and has confusion), DIZZINESS (Dizziness), CONFUSIONAL STATE (Does not remember things well and has confusion), PAIN IN EXTREMITY (Pain in the body and hands), PAIN (Pain in the body and hands), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 100.5 (High) 100.5 ° F.         No concomitant medications were provided by the reporter.  Patient also applied towel with cold water to treat the fever.   This case was linked to MOD-2021-075688, MOD-2021-075591 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Androgenetic alopecia
Clinical narrative: began to lose hair by the handfuls every time she combs her hair; Newbald spots; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (began to lose hair by the handfuls every time she combs her hair) and ANDROGENETIC ALOPECIA (Newbald spots) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had COVID in January 2021 where she was hospitalized for 10 days) in January 2021.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced ALOPECIA (began to lose hair by the handfuls every time she combs her hair) and ANDROGENETIC ALOPECIA (Newbald spots). At the time of the report, ALOPECIA (began to lose hair by the handfuls every time she combs her hair) and ANDROGENETIC ALOPECIA (Newbald spots) outcome was unknown.            No concomitant medications were provided No treatment medications were provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspepsia, Implant site pain, Lymph node pain
Clinical narrative: felt pressure under her implants; severe heartburn; pain in her chest; felt the lymph nodes under her left arm and described it as painful; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of IMPLANT SITE PAIN (felt pressure under her implants), DYSPEPSIA (severe heartburn), CHEST PAIN (pain in her chest) and LYMPH NODE PAIN (felt the lymph nodes under her left arm and described it as painful) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A2A1A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer, Mastectomy bilateral and Augmentation mammoplasty. Concomitant products included VITAMIN D NOS and ANASTROZOLE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced IMPLANT SITE PAIN (felt pressure under her implants), DYSPEPSIA (severe heartburn), CHEST PAIN (pain in her chest) and LYMPH NODE PAIN (felt the lymph nodes under her left arm and described it as painful). The patient was treated with DOXYCYCLINE at a dose of 10 days course. At the time of the report, IMPLANT SITE PAIN (felt pressure under her implants), DYSPEPSIA (severe heartburn), CHEST PAIN (pain in her chest) and LYMPH NODE PAIN (felt the lymph nodes under her left arm and described it as painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PYREXIA (low grade fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (low grade fever) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included  an unspecified high blood pressure medication.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood cholesterol and Hypertension. Concomitant products included ATORVASTATIN for Blood cholesterol, OMEPRAZOLE for Blood pressure high.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS. On 10-Apr-2021, INFLUENZA LIKE ILLNESS had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-076332.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Intermenstrual bleeding, Pain, Pyrexia
Clinical narrative: spotting (minimal but not the timing she normallyexperiences spotting with her menstrual cycle); fever of 104.3; Headaches; severe body aches; This spontaneous case was reported by a consumer and describes the occurrence of INTERMENSTRUAL BLEEDING (spotting (minimal but not the timing she normallyexperiences spotting with her menstrual cycle)), PAIN (severe body aches), PYREXIA (fever of 104.3) and HEADACHE (Headaches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (fever of 104.3). On 11-Apr-2021, the patient experienced INTERMENSTRUAL BLEEDING (spotting (minimal but not the timing she normallyexperiences spotting with her menstrual cycle)). In April 2021, the patient experienced PAIN (severe body aches) and HEADACHE (Headaches). At the time of the report, INTERMENSTRUAL BLEEDING (spotting (minimal but not the timing she normallyexperiences spotting with her menstrual cycle)) had not resolved and PAIN (severe body aches), PYREXIA (fever of 104.3) and HEADACHE (Headaches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 104.3 (High) 104.3.         No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed for shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Diagnosed for shingles) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced HERPES ZOSTER (Diagnosed for shingles). At the time of the report, HERPES ZOSTER (Diagnosed for shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: felt sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (felt sick). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ILLNESS (felt sick) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment reported: naproxen. No concomitant medications reported.
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Gait inability, Pain, Rash
Clinical narrative: confusion; can't walk; hurts all over; rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confusion), GAIT INABILITY (can't walk), PAIN (hurts all over) and RASH (rash on arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced CONFUSIONAL STATE (confusion), GAIT INABILITY (can't walk), PAIN (hurts all over) and RASH (rash on arm). At the time of the report, CONFUSIONAL STATE (confusion), GAIT INABILITY (can't walk), PAIN (hurts all over) and RASH (rash on arm) outcome was unknown.            No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site swelling, Musculoskeletal stiffness
Clinical narrative: Neck stiffness; Headaches; Swelling on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Neck stiffness), HEADACHE (Headaches) and INJECTION SITE SWELLING (Swelling on the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012l20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included DILTIAZEM HYDROCHLORIDE (CARTIA XT) and ALPRAZOLAM (XANAX) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Neck stiffness), HEADACHE (Headaches) and INJECTION SITE SWELLING (Swelling on the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. In March 2021, MUSCULOSKELETAL STIFFNESS (Neck stiffness), HEADACHE (Headaches) and INJECTION SITE SWELLING (Swelling on the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-075003 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache since last night; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache since last night) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced HEADACHE (Headache since last night). At the time of the report, HEADACHE (Headache since last night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not receive his second shot on time; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not receive his second shot on time) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive his second shot on time). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not receive his second shot on time) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: tingling on left side of the face; Tingling around the lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling on left side of the face) and PARAESTHESIA ORAL (Tingling around the lips) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PARAESTHESIA (tingling on left side of the face) and PARAESTHESIA ORAL (Tingling around the lips). At the time of the report, PARAESTHESIA (tingling on left side of the face) and PARAESTHESIA ORAL (Tingling around the lips) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain, Computerised tomogram, Gastrointestinal pain, Imaging procedure
Clinical narrative: Never had that pain before, still had almost every day little pain left; cramps in her intestine, never had that before; strange felling in her stomach; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 042L204) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach). The patient was treated with LIDOCAINE HYDROCHLORIDE (ASPERCREME WITH LIDOCAINE) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Computerised tomogram: normal (normal) shows nothing. In February 2021, Imaging procedure: normal (normal) shows nothing. In February 2021, Ultrasound abdomen: normal (normal) shows nothing.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound abdomen
Clinical narrative: Never had that pain before, still had almost every day little pain left; cramps in her intestine, never had that before; strange felling in her stomach; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 042L204) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach). The patient was treated with LIDOCAINE HYDROCHLORIDE (ASPERCREME WITH LIDOCAINE) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (Never had that pain before, still had almost every day little pain left), GASTROINTESTINAL PAIN (cramps in her intestine, never had that before) and ABDOMINAL DISCOMFORT (strange felling in her stomach) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Computerised tomogram: normal (normal) shows nothing. In February 2021, Imaging procedure: normal (normal) shows nothing. In February 2021, Ultrasound abdomen: normal (normal) shows nothing.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching around the injection site; more like a rash but without swelling; Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching around the injection site), VACCINATION SITE RASH (more like a rash but without swelling) and VACCINATION SITE ERYTHEMA (Redness around the injection site) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Cardiac operation NOS (Patient had a heart operation about six year ago.). Concurrent medical conditions included Drug allergy (sulfa). Concomitant products included LISINOPRIL, PRAVASTATIN and CLOPIDOGREL for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching around the injection site), VACCINATION SITE RASH (more like a rash but without swelling) and VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching around the injection site), VACCINATION SITE RASH (more like a rash but without swelling) and VACCINATION SITE ERYTHEMA (Redness around the injection site) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: itching on the injection site and it continued on until she had the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching on the injection site and it continued on until she had the 2nd dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE PRURITUS (itching on the injection site and it continued on until she had the 2nd dose). The patient was treated with PARACETAMOL (TYLENOL) for Injection site itching, at an unspecified dose and frequency. At the time of the report, INJECTION SITE PRURITUS (itching on the injection site and it continued on until she had the 2nd dose) had not resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.    This case was linked to MOD-2021-075016 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain, Rash, Vaccination site pain
Clinical narrative: arm hurt for a week and a half; throbbing; broke out like a rash a couple of days later; pain, same as when I had my first dose; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm), PAIN (throbbing), RASH (broke out like a rash a couple of days later), LIMB DISCOMFORT (arm hurt for a week and a half) and PAIN (pain, same as when I had my first dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In March 2021, the patient experienced VACCINATION SITE PAIN (pain in arm). On 07-Apr-2021, the patient experienced PAIN (pain, same as when I had my first dose). On 09-Apr-2021, the patient experienced RASH (broke out like a rash a couple of days later). On 12-Apr-2021, the patient experienced PAIN (throbbing). On an unknown date, the patient experienced LIMB DISCOMFORT (arm hurt for a week and a half). At the time of the report, VACCINATION SITE PAIN (pain in arm), PAIN (throbbing), RASH (broke out like a rash a couple of days later), LIMB DISCOMFORT (arm hurt for a week and a half) and PAIN (pain, same as when I had my first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient takes medication for Blood pressure (unspecified) No treatment medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075005 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075005:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Breast tenderness
Clinical narrative: tenderness and pain in her left breast; tenderness and pain in her left breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (tenderness and pain in her left breast) and BREAST TENDERNESS (tenderness and pain in her left breast) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 00721a and 012l20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included DILTIAZEM HYDROCHLORIDE (CARTIA XT) and ALPRAZOLAM (XANAX) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced BREAST PAIN (tenderness and pain in her left breast) and BREAST TENDERNESS (tenderness and pain in her left breast). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BREAST PAIN (tenderness and pain in her left breast) and BREAST TENDERNESS (tenderness and pain in her left breast) was resolving. Not Provided          Patient was also taking an unspecified blood pressure medication as a concomitant mediation.   This case was linked to MOD-2021-074995 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Crying, Emotional disorder
Clinical narrative: worried; crying; Confused; upset; This spontaneous case was reported by a consumer and describes the occurrence of CRYING (crying), CONFUSIONAL STATE (Confused), EMOTIONAL DISORDER (upset) and ANXIETY (worried) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced CRYING (crying), CONFUSIONAL STATE (Confused) and EMOTIONAL DISORDER (upset). On an unknown date, the patient experienced ANXIETY (worried). On 13-Apr-2021, CRYING (crying) and EMOTIONAL DISORDER (upset) had resolved. At the time of the report, CONFUSIONAL STATE (Confused) and ANXIETY (worried) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Rash
Clinical narrative: arm hurt for a week and a half; it is throbbing; broke out like a rash a couple of days later; Pain, same as when I had my first dose; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain, same as when I had my first dose), PAIN IN EXTREMITY (arm hurt for a week and a half), RASH (broke out like a rash a couple of days later) and PAIN IN EXTREMITY (it is throbbing) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included High blood pressure medication for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PAIN (Pain, same as when I had my first dose). On 09-Apr-2021, the patient experienced RASH (broke out like a rash a couple of days later). On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (it is throbbing). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt for a week and a half). At the time of the report, PAIN (Pain, same as when I had my first dose), PAIN IN EXTREMITY (arm hurt for a week and a half), RASH (broke out like a rash a couple of days later) and PAIN IN EXTREMITY (it is throbbing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-075002 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075002:1st dose case